Anti-Acidic Mammalian Chitinase Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibodies targeting acidic mammalian chitinase (CHIA), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-
UniProt
Q9BZP6
Size
100ug
Cat. #
RP1Acidic Mammalian Chitinase

In stock

SKU
RP-Acidic Mammalian Chitinase

Options

As low as: $130.00

Target Overview

Acidic mammalian chitinase (AMCase, EC 3.2.1.14) is a secreted hydrolase encoded by the CHIA gene (UniProt Q9BZP6) that catalyzes the degradation of chitin and chitotriose. The 476-amino acid enzyme functions primarily in innate immune defense against chitin-containing pathogens including nematodes and fungi. AMCase is expressed in multiple tissues with notable abundance in lung epithelium, where it was originally identified as lung-specific protein TSA1902. The enzyme plays a dual role in Th2-mediated immunity: it degrades environmental chitin while also modulating inflammatory signaling in response to IL-13. Beyond its enzymatic activity, AMCase exhibits cytoprotective functions in pulmonary epithelial cells, stimulating chemokine production and promoting AKT1 phosphorylation to protect against apoptosis. These non-catalytic functions are inhibited by the chitinase inhibitor allosamidin, indicating that carbohydrate-binding activity is required for both enzymatic and signaling roles. The protein's participation in allergic airway inflammation and asthma pathogenesis has made it a target of interest in respiratory immunology research.

Background

AMCase contributes to host defense through direct chitinolytic activity and indirect modulation of epithelial inflammatory responses. Its expression is upregulated in Th2-polarized conditions and it serves as an effector molecule downstream of IL-13 signaling in the lung. The enzyme's ability to cleave chitin polymers positions it as a first-line defense against fungal cell walls and parasitic exoskeletons, while its capacity to stimulate chemokine secretion from airway epithelium coordinates recruitment of additional immune cells. The dual requirement for catalytic activity and carbohydrate binding in AMCase-mediated cytoprotection distinguishes it from related chitinase-like proteins that lack hydrolytic function. Recent profiling studies have examined chitinases and related glycosidases in the context of immune cell dynamics and tissue-specific biomarker discovery. Multi-omics approaches continue to identify enzyme families involved in lysosome-associated processes and cellular stress responses across diverse pathological contexts. The chitinase family, including both catalytically active and lectin-like members, remains an area of active investigation in inflammatory disease and cancer biology, though AMCase itself is most extensively characterized in pulmonary and gastrointestinal immunity. Five rabbit polyclonal antibodies raised against the aminoterminus of mature AMCase are available through Triple Point Biologics, offering coverage of the N-terminal catalytic domain. These reagents have been validated for detection of human CHIA in Western blot applications. Immunohistochemistry (IHC) and immunofluorescence (IF) validation is currently in progress, supporting functional studies of chitinase activity in immune and epithelial cell systems.

References

  1. Palekkode N et al (2026) Multi-omics profiling identifies ACP2 as a lysosome-associated biomarker linked to immune dynamics and clinical outcomes in glioma. Comput Biol Chem. PubMed · 10.1016/j.compbiolchem.2026.109165

Additional Specifications

Gene Symbol CHIA
UniProt ID Q9BZP6
Host Species Rabbit
Species Reactivity Validated- Human
Potential-
Pack Size 100ug
Immunogen (Aminoterminus of mature AMC)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 22-72.
Immunogen (Amino end of the catalytic domainÂ)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 22-62.
Immunogen (Carboxy end of the catalytic domainÂ)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 436-476.
Immunogen (Hinge regionÂ)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 390-420.
Immunogen (Chitin binding domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 427-476.
Alternate Names AMCase, Acidic mammalian chitinase, CHIA, EC 3.2.1.14, Lung-specific protein TSA1902

Frequently Asked Questions

What molecular weight should I expect for AMCase on a Western blot?

Human acidic mammalian chitinase (AMCase) migrates at approximately 50-52 kDa on reducing SDS-PAGE, though the predicted molecular weight from the 476-amino acid sequence is closer to 52.5 kDa. The enzyme undergoes N-glycosylation, which can shift the apparent mass slightly depending on cell type and post-translational modifications. If you're working with conditioned media or secreted fractions, expect a mature glycosylated form. Deglycosylation with PNGase F can help confirm identity if you observe heterogeneous banding. Always include a positive control lysate from lung or gastrointestinal epithelium where AMCase is abundantly expressed.

Does this antibody cross-react with mouse or rat AMCase?

This antibody is validated for human AMCase. Cross-reactivity with mouse or rat orthologs is not experimentally validated but may occur given the moderate sequence conservation of the chitinase catalytic domain across mammalian species. Human and mouse AMCase share approximately 60-65% amino acid identity. If you're working with rodent samples, we recommend treating this as a predicted cross-reactivity and verifying performance with a known positive control such as mouse lung lysate from IL-13-treated animals, where AMCase is upregulated. Titrate dilutions starting at 1:500 to 1:2000 for initial optimization.

What starting dilution should I use for Western blot with this AMCase antibody?

Start at 1:1000 in 5% non-fat milk or BSA in TBST for Western blot, as recommended. This dilution typically provides clean signal with low background for polyclonal antibodies in our chitinase portfolio. If your AMCase expression is low or you're working with non-lung tissues where endogenous levels are modest, try 1:500. Conversely, if background is high, dilute to 1:2000. Incubate overnight at 4°C for optimal epitope binding. We've generated this rabbit polyclonal against a large immunogen spanning most of the mature enzyme, so sensitivity is generally robust across denatured samples.

Can I use this antibody for immunohistochemistry on lung tissue?

Yes, Triple Point Biologics antibodies are validated for Western blot. Immunohistochemistry (IHC) and immunofluorescence (IF) validation is currently in progress. For AMCase detection in paraffin-embedded lung sections, standard antigen retrieval with citrate buffer (pH 6.0) at sub-boiling temperature typically works well. AMCase localizes primarily to bronchial and bronchiolar epithelium, with increased staining in asthmatic or allergen-challenged tissue where IL-13 drives expression. Start with a 1:100-1:200 dilution for IHC and include adjacent sections incubated with rabbit IgG as a negative control. Expect both cytoplasmic and secreted extracellular staining patterns depending on activation state.

What are good positive and negative control samples for AMCase Western blots?

Human lung epithelial cell lysates (primary or A549 line) serve as excellent positive controls, particularly if treated with IL-13 for 24-48 hours to induce AMCase expression. Gastric mucosa also expresses AMCase constitutively. For a negative control, use tissues with minimal chitinase expression such as liver, skeletal muscle, or brain lysate. If studying disease models, compare samples from allergen-challenged versus naive animals or tissue. Running recombinant human AMCase as a reference standard is ideal but not always accessible. Always verify loading with a housekeeping protein like beta-actin or GAPDH.

Does AMCase have isoforms or splice variants I should know about?

The CHIA gene encoding AMCase does not have well-characterized splice variants that significantly alter protein structure or antibody recognition. The primary transcript yields the 476-amino acid preproprotein, which undergoes signal peptide cleavage to generate the mature secreted enzyme. Some databases list minor transcript variants, but these have not been validated at the protein level. You should observe a single predominant band around 50-52 kDa under standard conditions. If you see multiple bands, consider glycosylation heterogeneity, proteolytic processing in certain tissue contexts, or non-specific binding requiring further optimization of blocking and dilution conditions.

How should I store this AMCase antibody and what is the shelf life?

Store the antibody at -20°C in small aliquots to avoid repeated freeze-thaw cycles, which can compromise polyclonal antibody performance over time. The 100 µg pack size is supplied in a stabilization buffer; check the product datasheet for specific formulation details such as glycerol content, which affects freezing behavior. Under these conditions, the antibody typically remains stable for at least 12 months from date of receipt. Once thawed, an aliquot can be stored at 4°C for up to one month if you're using it frequently. Avoid prolonged exposure to room temperature and never refreeze a working aliquot.

Will this antibody detect AMCase enzymatic activity or only protein presence?

This is an immunological reagent that detects AMCase protein by epitope recognition, not enzymatic activity. It will bind both active and inactive forms of the enzyme, including catalytically dead mutants or improperly folded protein. If your research question centers on functional chitinase activity rather than expression levels, you'll need a separate enzymatic assay using fluorogenic chitin substrates like 4-methylumbelliferyl chitotriose. The antibody is valuable for confirming AMCase localization, quantifying expression changes in response to stimuli like IL-13, or detecting the protein in tissue lysates where activity assays may be confounded by other chitinase family members.

Validation imagery coming soon

Western blot validation figures for RP-Acidic Mammalian Chitinase will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • AMCase
  • Acidic mammalian chitinase
  • CHIA
  • EC 3.2.1.14
  • Lung-specific protein TSA1902
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →